{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:26:50Z","timestamp":1767162410579,"version":"build-2238731810"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/1751-486x.12006","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T12:25:55Z","timestamp":1360585555000},"page":"53-58","source":"Crossref","is-referenced-by-count":6,"title":["New Developments in the Pharmacologic Treatment of Obesity"],"prefix":"10.1016","volume":"17","author":[{"given":"Heidi Collins","family":"Fantasia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1751-486X.12006_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhealeco.2011.10.003","article-title":"The medical care costs of obesity: An instrumental variables approach","volume":"31","author":"Cawley","year":"2012","journal-title":"Journal of Health Economics"},{"key":"10.1111\/1751-486X.12006_bb0015","first-page":"675","article-title":"Limitations in anti\u2010obesity drug development: The critical role of hunger\u2010promoting neurons","volume":"11","author":"Dietrich","year":"2012","journal-title":"Nature Reviews"},{"key":"10.1111\/1751-486X.12006_bb0020","series-title":"Belviq\u00ae [package insert]","author":"Eisai Pharmaceuticals","year":"2012"},{"key":"10.1111\/1751-486X.12006_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and sever obesity forecasts through 2030","volume":"42","author":"Finkelstein","year":"2012","journal-title":"American Journal of Preventative Medicine"},{"key":"10.1111\/1751-486X.12006_bb0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body\u2010mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country\u2010years and 9.1 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/1751-486X.12006_bb0035","series-title":"FDA news release","author":"Food and Drug Administration","year":"2012"},{"key":"10.1111\/1751-486X.12006_bb0040","series-title":"FDA news release","author":"Food and Drug Administration","year":"2012"},{"key":"10.1111\/1751-486X.12006_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/clp.11.65","article-title":"A review of topriamate and phentermine: A combine therapeutic approach for obesity","volume":"7","author":"Gadde","year":"2012","journal-title":"Clinical Lipidology"},{"key":"10.1111\/1751-486X.12006_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1542-2011.2012.00180.x","article-title":"Contraception and antiepileptic drugs","volume":"57","author":"Guillemette","year":"2012","journal-title":"Journal of Midwifery and Women's Health"},{"issue":"4","key":"10.1111\/1751-486X.12006_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topriamate in pregnancy: Preliminary experience from the UK epilepsy and pregnancy register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/1751-486X.12006_bb0060","series-title":"NCHS Data Brief, no. 82","article-title":"Prevalence of obesity in the United States, 2009\u20132010","author":"Ogden","year":"2012"},{"key":"10.1111\/1751-486X.12006_bb0065","series-title":"Qsymia [package insert]","author":"Vivus, Inc.","year":"2012"},{"key":"10.1111\/1751-486X.12006_bb0070","first-page":"669","article-title":"The pharmaceutical market for obesity therapies","volume":"11","author":"Wong","year":"2012","journal-title":"Nature Reviews"},{"key":"10.1111\/1751-486X.12006_bb0075","series-title":"Obesity and overweight","author":"World Health Organization","year":"2012"}],"updated-by":[{"DOI":"10.1111\/1751-486x.12029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000}}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T16:58:54Z","timestamp":1539881934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485115307261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1751485115307261"],"URL":"https:\/\/doi.org\/10.1111\/1751-486x.12006","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}